Loading clinical trials...
Loading clinical trials...
To explore the efficacy and safety of minimally invasive suprachoroidal drainage for the treatment of advanced neovascular glaucoma
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhongnan Hospital
NCT07177807 · Neovascular Glaucoma
NCT05156021 · Neovascular Glaucoma, Proliferative Diabetic Retinopathy
NCT02805257 · Glaucoma, Primary Open Angle Glaucoma, and more
NCT03154892 · Neovascular Glaucoma
NCT02067013 · Proliferative Diabetic Retinopathy, Macular Degeneration, and more
Zhongnan Hospital of Wuhan University
Wuhan, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions